Company intelligence / Profile preview

Inaphaea BioLabs

Ownership: Private
Development stage: Commercial

Overview

Inaphaea BioLabs provides advanced cell-based and immunological assay services to support early-stage drug discovery and preclinical development, with a focus on oncology and women’s health. The company specializes in generating high-quality data to improve the translation of candidate drugs toward clinical evaluation. It does not develop its own pipeline of therapeutic products but supports clients’ programs through contract research offerings.

Therapeutic areas: OncologyWomen's Health
Modalities: Small moleculeBiologicProteinCell therapy
Industry: Drug Discovery Services

Partnerships

Agility Life Sciences (formulation development/CDMO partnership)Physiomics plc (biological modeling/data analysis partnership)Inspiralis Ltd. (enzyme assay kits/services partner)DefiniGEN Ltd. (“Opti-Heps” liver model technology partner)Ignota Labs Ltd. (“AI toxicity prediction” partner)Dominion Biotech Ltd.

Beyond the preview

Go deeper on Inaphaea BioLabs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inaphaea BioLabs.

Explore the full profile